SCHEMBL12197809

SCHEMBL12197809

c1ccc(-c2c(-c3ccccc3)n(-c3cccc(-c4ccncc4)n3)c3c4ccccc4c4cc(-c5cccc(-c6ccncc6)n5)c5ccccc5c4c23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ HPGD P15428 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ LMNA P02545 3/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ MEN1 O00255 4/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ RECQL P46063 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ DHODH Q02127 1/20 0.32
▸ PDE10A Q9Y233 1/20 0.31
▸ SQOR Q9Y6N5 1/20 0.31
▸ POLB P06746 2/20 0.31
▸ THRB P10828 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ CYP2C9 P11712 2/20 0.30
▸ RAD52 P43351 1/20 0.30
▸ NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12197792 0.88 MAPK10 (0.38) ALDH1A1KDM4EHPGDMAPTRAB9A
SCHEMBL12197817 0.84 RAB9A (0.36) ALDH1A1KDM4EHPGDMAPTLMNA
SCHEMBL12197831 0.84 KDM4E (0.33) ALDH1A1KDM4EHPGDMAPTLMNA
SCHEMBL12315011 0.83 KMT2A (0.36) ALDH1A1KDM4EHPGDMAPTLMNA
SCHEMBL12197825 0.83 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDMAPTLMNA
SCHEMBL12197805 0.82 KMT2A (0.40) ALDH1A1KDM4EHPGDMAPTLMNA
SCHEMBL12031940 0.82 KMT2A (0.36) ALDH1A1KDM4EHPGDMAPTLMNA
SCHEMBL12197811 0.82 RAB9A (0.36) ALDH1A1KDM4EHPGDMAPTLMNA
SCHEMBL12197796 0.82 — —
SCHEMBL12197772 0.81 KDM4E (0.33) ALDH1A1KDM4EHPGDMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8384074-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2013-02-26 — — US disclosed
US-8384074-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2013-02-26 — — US disclosed
US-20110240978-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD (KR) 2011-10-06 — — US disclosed
US-20110240978-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD (KR) 2011-10-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110240978-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME LEF1, IDO1, NOD1 ALDH1A1 837/4885KDM4E 2764/4885HPGD 1455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback